Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2012
02/09/2012WO2012016427A1 Culture medium of pig cells
02/09/2012WO2011159758A3 Long lasting drug formulations
02/09/2012WO2011119805A3 Compositions comprising high molecular weight hyaluronic acid and methods for producing same
02/09/2012US20120036601 Broccoli Type Adapted for Ease of Harvest
02/09/2012US20120036600 Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins
02/09/2012US20120036596 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
02/09/2012US20120036595 Whole Seed Specific Promoter
02/09/2012US20120036594 RNA-Mediated Induction of Gene Expression in Plants
02/09/2012US20120036593 Plant Promoter Operable in Endosperm and Uses Thereof
02/09/2012US20120036592 Process for Producing a Hybrid Maize Having Insulated Casing and Individual Shield for Grains, by Means of a Genetic Tool, and a Hybrid Maize Thereof
02/09/2012US20120036590 Interferon-like protein zcyto21
02/09/2012US20120036589 Vaccine
02/09/2012US20120036588 Method for observing gad67-positive cell in transgenic animal
02/09/2012US20120036587 Prostate cancer cell lines and their use in screening method
02/09/2012US20120035354 Materials and methods for the modification of plant lignin content
02/09/2012US20120035276 Tissue regenerative composition, method of making, and method of use thereof
02/09/2012US20120035246 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
02/09/2012US20120035244 Parp1 targeted therapy
02/09/2012US20120035240 Conserved hbv and hcv sequences useful for gene silencing
02/09/2012US20120035200 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
02/09/2012US20120035184 Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase i inhibitors
02/09/2012US20120035179 Modulators of atp-binding cassette transporters
02/09/2012US20120035161 Novel Compositions and Methods of Treating Diseases Using the Same
02/09/2012US20120035132 Boron-containing small molecules
02/09/2012US20120035119 Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss
02/09/2012US20120035112 Neuronal differentiation-inducing peptide and use thereof
02/09/2012US20120035079 Genotoxicity testing
02/09/2012US20120035077 Modified renilla luciferase nucleic acids and methods of use
02/09/2012US20120035065 Aptamer Regulated Nucleic Acids and Uses Thereof
02/09/2012US20120034697 In vitro methods for the induction and maintenance of plant cell lines as single suspension cells with intact cell walls, and transformation thereof
02/09/2012US20120034696 Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
02/09/2012US20120034695 Tissue/cell culturing system and related methods
02/09/2012US20120034694 Cell culture support and cell culture method
02/09/2012US20120034693 Recombinant vector and use in gene therapy
02/09/2012US20120034692 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
02/09/2012US20120034691 Genetically encoded calcium indicators and methods of use
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034677 Microorganism culture device and method of operation thereof
02/09/2012US20120034676 Seneca valley virus based compositions and methods for treating disease
02/09/2012US20120034675 Tyrosinase mutant and methods of use thereof
02/09/2012US20120034673 Isolated plant deoxyhypusine synthase and nucleotides encoding same
02/09/2012US20120034672 Superluminescent luciferase variant with prolonged bioluminescence
02/09/2012US20120034661 Strains for the production of flavonoids from glucose
02/09/2012US20120034657 Thrombopoietic compounds
02/09/2012US20120034656 Neutralising Antibody Molecules Having Specificity for Human IL-17
02/09/2012US20120034655 Fsh producing cell clone
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034643 Fluorescent protein
02/09/2012US20120034642 Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans
02/09/2012US20120034630 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD)
02/09/2012US20120034625 Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1
02/09/2012US20120034618 Methods for culture and production of single cell populations of human embryonic stem cells
02/09/2012US20120034616 Method for Modulating Epithelial Stem Cell Lineage
02/09/2012US20120034604 Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
02/09/2012US20120034595 Enriched stem cell and progenitor cell populations, and methods of producing and using such populations
02/09/2012US20120034299 Compositions for the treatment of gluten intolerance and uses thereof
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034257 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
02/09/2012US20120034251 Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity
02/09/2012US20120034245 Single-chain multivalent binding proteins with effector function
02/09/2012US20120034237 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
02/09/2012US20120034234 Methods for the treatment or prevention of systemic sclerosis
02/09/2012US20120034232 Tlr3 binding agents
02/09/2012US20120034231 Compositions and methods of use for therapeutic antibodies
02/09/2012US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA
02/09/2012US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
02/09/2012US20120034228 CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
02/09/2012US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof
02/09/2012US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof
02/09/2012US20120034219 Uses of il-23 agonists and antagonists; related reagents
02/09/2012US20120034215 Anti-mst1r antibodies and uses thereof
02/09/2012US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases
02/09/2012US20120034211 EGFR antibodies comprising modular recognition domains
02/09/2012US20120034206 Breast cancer eradication program
02/09/2012US20120034204 Fertilization modulation compounds and process for implementing them
02/09/2012US20120034197 Hiv-resistant stem cells and uses thereof
02/09/2012US20120034196 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof (frank)
02/09/2012US20120034195 Placental stem cells derive from post-partum manmalian placenta, and uses and methods of treatment using said cells
02/09/2012US20120034194 Somatic Stem Cells
02/09/2012US20120034192 Compositions and methods for enhancing cell reprogramming
02/09/2012US20120034189 Means and methods for durable inhibition of pathogens
02/09/2012US20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof
02/09/2012US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use
02/09/2012US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof
02/09/2012US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
02/09/2012US20120034162 Fullerene Assisted Cell Penetrating Peptides
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012US20120034159 Antibodies that bind both bcma and taci
02/09/2012US20120034157 Artificial cells
02/09/2012CA2807552A1 Engineered nucleic acids and methods of use thereof
02/09/2012CA2807438A1 Circulation system
02/09/2012CA2807418A1 Simplified basic media for human pluripotent cell culture
02/09/2012CA2807035A1 Mutated protoporphyrinogen ix oxidase (ppx) genes
02/09/2012CA2806858A1 Reprogramming immortalized b cells
02/09/2012CA2806427A1 Compositions for proliferation of cells and related methods
02/09/2012CA2799516A1 Immunological function enhancing agent
02/08/2012EP2415868A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
02/08/2012EP2415862A1 Method for inducing cell death in pluripotent stem cells and differentiated cells other than cardiac myocytes
02/08/2012EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
02/08/2012EP2414539A2 Methods and devices for sorting cells and other biological particulates
1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 1827